Pharmacokinetic equivalence study of nonsteroidal anti-inflammatory drug etoricoxib
Raymond R Tjandrawinata,1 Arini Setiawati,2 Dwi Nofiarny,1 Liana W Susanto,1 Effi Setiawati3 1Dexa Laboratories of Biomolecular Sciences Unit, Dexa Medica Group, Cikarang, West Java, Indonesia; 2Department of Pharmacology and Therapeutics, Medical Faculty, University of Indonesia, Jakarta, Indonesia...
Guardado en:
Autores principales: | Tjandrawinata RR, Setiawati A, Nofiarny D, Susanto LW, Setiawati E |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ffa0af854e66411f82e0a722b4e6620e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
THEORETICAL INVESTIGATION OF THE MOLECULAR STRUCTURE AND MOLECULAR DOCKING OF ETORICOXIB
por: Sadasivam,Kandasamy, et al.
Publicado: (2020) -
Pharmacokinetic equivalence study of two formulations of the anticonvulsant pregabalin
por: Tjandrawinata RR, et al.
Publicado: (2015) -
Bioequivalencia de una formulación nacional de Ambroxol
por: SAAVEDRA S.,IVÁN, et al.
Publicado: (2003) -
Sterols from Jatropha tanjorensis leaves exhibit anti-inflammatory potential: in vitro and in silico studies
por: Damilola Alex Omoboyowa
Publicado: (2021) -
Eudragit®-S100 Coated PLGA Nanoparticles for Colon Targeting of Etoricoxib: Optimization and Pharmacokinetic Assessments in Healthy Human Volunteers
por: El-Maghawry E, et al.
Publicado: (2020)